Header image.

Home

Dr. Marcel Lindemann has been to the Tromsø University Museum (Norges arktiske universitetsmuseum) to check radioactive stones for his radiochemistry course teaching

Dr. Marcel Lindemann has been to the Tromsø University Museum (Norges arktiske universitetsmuseum) to check radioactive stones that were collected by Hans Morten Thrane Esmark about 180 years ago. Dr. Lindemann made use of the stones in his radiochemistry course to show the students how we humans discovered substances in nature that today benefit us Read More

180N-preclinical (Tromsø) workshop, Feb 2021

The 180N-preclinical workshop was held in Tromsø and online on 15 Feb 2021.

“Helse Nords forskningsmidler” funding granted

Funding application to the “Helse Nords forskningsmidler” for the project “Branching out – Development of radiocopper (Cu-64/Cu-67) radiopharmaceuticals for precision medicine theranostics in glioblastoma vascularization” has been granted. Project leader: Mathias Kranz. Congratulations!

New video: Tromsø PET Imaging Center

Check out the new video: Tromsø PET Imaging Center University Hospital of North Norway & UiT The Arctic University of Norway Presented at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting (SNMMI), 2020 & 2021

The Brain Tumor Workshop was held by our research group in Tromsø on 11-12 February 2020

An article entitled “Alternative biomarkers for immunotherapy” authored by Turid Hellevik and Inigo Martinez Zubiaurreis is published in Tidsskrift for Den norske legeforening

To cite this article: Hellevik, Turid, and Iñigo Martinez-Zubiaurre. “Alternative biomarkers for immunotherapy.” Tidsskrift for Den norske legeforening (2019). DOI: 10.4045/tidsskr.19.0454

The first Scientific Advisory Board meeting of 180N-Tromsø project

The first Scientific Advisory Board meeting of 180N-Tromsø project was held in Tromsø on 20-21 Jan 2020. 

An article published in Molecules coauthored by Mathias Kranz

The article is entitled “Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine- Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography” published in Molecules 2019, 24(22), 4149; https://www.mdpi.com/1420-3049/24/22/4149.

Mathias Kranz is awarded a research grant from Familien Blix` fond

Researcher Mathias Kranz is awarded a research grant from Familien Blix` fond (the Blix Family Fund) for the project “Small animal imaging of Glioblastoma – Comparing [18F]PSMA and [18F]fluciclovine to [18F]FET for application as diagnostic tool for Positron Emission Tomography (PET).” Congratulations!

Check out our open positions!

1) PhD Candidate in Nuclear Medicine/PET 2) Researcher in Nuclear Medicine and Radiation Biology ** Application deadline: 10th September 2019

Next Entries »